From Washington’s vantage point, a full-fledged tariff on patented and branded products is meant to boost domestic manufacturing in the country, but there are caveats.
Source link
Tariffs On Pharma: A Double-Edged Sword For The US?
Related Posts
Most Crypto Tokens Aren’t Securities, Pitches Unified Rulebook
US Securities and Exchange Commission (SEC) Chair Paul Atkins said that “most crypto tokens are not securities,” while outlining a…
SwissBorg loses 193K SOL in Solana exploit
Key Takeaways SwissBorg lost 192,600 SOL worth $41.5 million in a Solana blockchain exploit. The incident was first reported by…
At Modi-Ishiba meet, pact on Moon exploration, supply chains for chips and rare earths | India News
Among the key outcomes of Prime Minister Narendra Modi’s Japan visit was an agreement between the space agencies of both…